Select Language

MYoroface – The company behind IQoro

Myoroface is the company behind IQoro. We are a research-based healthtech company based in Hudiksvall in northern Sweden.

Improve quality of life

IQoro contributes to an improved quality of life by treating the root cause behind some of the most common public diseases.

  • 97% improve their symptoms, sleep better and get the opportunity to reduce their medication.

We are doing everything we can to ensure that our customers succeed with their treatment. That’s something we are very proud of.

Våra kärnvärden

IQoro ger inga biverkningar
IQoro ger inga biverkningar

Engagemang

Vi brinner för att hjälpa människor. Vi tror att vi gör det bäst genom att engagerat bidra med det vi är experter på.

IQoro ger inga biverkningar

Nyfikenhet

Som en startup inom medtech är vi nyfikna. Vi ställer frågor, funderar på nya lösningar och vill ta reda på mer.

IQoro ger inga biverkningar

Omtanke

Hjärtat i vårt företag är vår omtanke. Omtanken om våra kunder och deras hälsa, men också omtanken om varandra.

IQoro ger inga biverkningar

Lösningsfokus

Vi gör allt för att våra kunder ska lyckas med sin behandling. Vi ser möjligheter istället för problem.

Forskaren Mary Hägg håller i sin innovation IQoro
Mary Hägg, Associate Professor and innovator

The innovator behind IQoro

Mary Hägg is both the brain and the heart behind IQoro.

With great patience and impressive anatomical knowledge, she has spent the majority of her professional life creating and developing IQoro.

Team IQoro

Styrelse och anställda på MYoroface

Working with IQoro means doing good things! We are a healthtech company that really cares about our customers. If you ask any of our employees what they think is the best thing about working with us, you will almost always get the same answer: We love helping people to a better quality of life.

IQoro as a part of your daily routine

Work with us!

We are constantly growing, and are therefore always on the lookout for new talents. Maybe you will become our next colleague?

The MYoroface board of directors

Tua Holgersson i MYoroface styrelse

Tua Holgersson

Chairman of the Board
CEO, Bliwa

LinkedIn

Andreas Anderzoni MYoroface styrelse

Andreas Anderzon

CEO, D&A group

LinkedIn

Henrik Rammer i MYoroface styrelse

Henrik Rammer

Private investor

LinkedIn

Marie Andersson i MYoroface styrelse

Marie Andersson

Investment manager,
Almi Invest

LinkedIn

Linn Hägg

Co-funder and owner

LinkedIn

Ylvali Gerling

Co-funder and owner

LinkedIn

The MYoroface management team

Ylvali Gerling
Co-founder, CEO

Linkedin

Maria Gårdlund

Maria Gårdlund

COO, VP

Linkedin

Johan Hedqvist

Johan Hedqvist

CFO

Linkedin

Linn Hägg

Co-founder, CBDO

Linkedin

Linda Joneland

Linda Joneland

Communications Director

Linkedin

Torbjörn Sandblad

Head of Digital Sales

Linkedin

Partnership with RefluxUK

We are partnering with RefluxUK – the largest reflux specialist clinic in the UK.

Read more about RefluxUK

Milestones

MYoroface was founded in 2012 and completed its first investment round in 2014 for continued market expansion.

Among the investors are ALMI Invest, Karlsarvet Invest and the Swedish Dragons’ Den profile Shervin Razani.

The company’s growth took off when IQoro began to be sold directly to consumers in the Nordics and the UK. Today IQoro is used by more than 100,000 people, and since May 2022 the product can be prescribed throughout the UK.

Important milestones in the history of MYoroface
Important milestones in the history of MYoroface
IQoro är en CE-märkt produkt
Godkänd av NICE i UK
MYoroface är medlem i Swedish Medtech
IQoro går att få på recept via NHS i Storbritannien
IQoro is shortlisted for the Bionow ‘Product of the Year’ Award

Contact

Call us from the UK: 01229 444 823
Call us from other countries +46 10 551 67 22
Email: info@iqoro.com

Organization number: 556902-6791

Press & Media

Hudiksvall (HQ)

MYoroface AB
Sjötullsgatan 16
824 55 Hudiksvall
Sweden

Göteborg:

MYoroface AB
c/o Mindpark Göteborg Central
Lilla Bommen 3
411 04 Göteborg

Sweden